CN106491996A - 一种治疗狂躁症的中药组合物及其制备方法 - Google Patents
一种治疗狂躁症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN106491996A CN106491996A CN201611246700.4A CN201611246700A CN106491996A CN 106491996 A CN106491996 A CN 106491996A CN 201611246700 A CN201611246700 A CN 201611246700A CN 106491996 A CN106491996 A CN 106491996A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- manic disorder
- rhizoma gastrodiae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 239000000203 mixture Substances 0.000 title claims abstract description 51
- 208000020925 Bipolar disease Diseases 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 241001504654 Mustela nivalis Species 0.000 claims abstract description 52
- 241000208966 Polygala Species 0.000 claims abstract description 41
- 244000001632 Acorus gramineus Species 0.000 claims abstract description 40
- 235000013073 Acorus gramineus Nutrition 0.000 claims abstract description 39
- 241000222336 Ganoderma Species 0.000 claims abstract description 38
- 239000000843 powder Substances 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 19
- 239000006187 pill Substances 0.000 claims description 17
- 210000001835 viscera Anatomy 0.000 claims description 12
- 235000020097 white wine Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 235000014101 wine Nutrition 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 208000020016 psychiatric disease Diseases 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 4
- 238000009472 formulation Methods 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 230000006870 function Effects 0.000 abstract description 11
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 8
- 208000026435 phlegm Diseases 0.000 abstract description 8
- 208000003443 Unconsciousness Diseases 0.000 abstract description 3
- 230000002618 waking effect Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 201000010099 disease Diseases 0.000 description 14
- 238000000034 method Methods 0.000 description 11
- 229940079593 drug Drugs 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 230000036651 mood Effects 0.000 description 7
- 238000011084 recovery Methods 0.000 description 6
- 230000000306 recurrent effect Effects 0.000 description 6
- -1 Vina Substances 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 206010057315 Daydreaming Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010026749 Mania Diseases 0.000 description 3
- 244000000231 Sesamum indicum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 230000002460 anti-migrenic effect Effects 0.000 description 3
- 230000006399 behavior Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000027534 Emotional disease Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010016777 Flight of ideas Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000004050 mood stabilizer Substances 0.000 description 2
- 229940127237 mood stabilizer Drugs 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000544682 Acorus tatarinowii Species 0.000 description 1
- 206010002820 Antisocial behaviour Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 241001489091 Ganoderma sinense Species 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000035154 Hyperesthesia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241001504651 Mustela sibirica Species 0.000 description 1
- 241000282331 Mustelidae Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001080798 Polygala tenuifolia Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910052808 lithium carbonate Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/882—Acoraceae (Calamus family), e.g. sweetflag or Acorus calamus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗狂躁症的中药组合物及其制备方法,由以下重量份的组分组成:天麻10‑50份、黄鼠狼30‑70份、灵芝10‑30份、石昌蒲10‑30份、远志10‑30份。本发明组方严谨,药少力专,具有涤痰开窍、安神益智功能的功效,对狂躁症有良好的疗效。
Description
技术领域
本发明涉及药品领域,具体涉及一种治疗狂躁症的中药组合物及其制备方法。
背景技术
狂躁症是一种精神疾病的表现,随着电脑、手机等数码产品的普及使用,以及现代人生活、工作压力的增大,狂躁症发病率逐年升高,不良的生活事件和环境应激事情事件也可诱发狂躁症的发作。躁狂症易反复发作,长期的反复发作,导致患者疾病慢性化、人格改变和社会功能受损,对患者的工作和生活都会造成严重影响。
目前,狂躁病在药物治疗方面,主要以心境稳定剂治疗为主,心境稳定剂可以治疗和预防发作,其主要作用是对紊乱的大脑神经化学过程进行调整,控制大脑兴奋,仅仅是控制疾病的症状,并未从病因上治疗。虽然,西药在治疗狂躁症上有起效快,作用明显的优点,但是由于其治标不治本,因此大多数患者容易复发,而且西药治疗疾病容易生产依赖性,副作用大。
中药是我国特有的中医药理论与实践的产物,资源丰富,历史悠久,是人类最早应用的纯天然有机物质。而精神疾病隶属于中医情志病范畴,中医学对情志病的认识已有二千余年的历史,在情志病的病因、病机、预防、治疗等方面形成了独特的理论体系和丰富的实践经验。中医采用以调理情绪,醒脑开窍、疏肝涤痰、调理气血,调整机体的脏腑功能及平衡阴阳作用的中药治疗精神疾病,回避了西药治疗时容易产生药物依赖,副作用大等问题,固本培元,标本兼治,达到根治的目的。本发明通过中医理论指导,科学配方,对狂躁症有良好的疗效。本发明外尚未见天麻、黄鼠狼、灵芝、石昌蒲和远志组合物的报道。
(1)天麻,为兰科植物天麻Gastrodia elata Bl.的干燥块茎。收载于中国药典2015年版:【性味与归经】甘,平。归肝经。【功能与主治】息风止痉,平抑肝阳,祛风通络。用于小儿惊风癫痫抽搐,破伤风,头痛眩晕,手足不遂,肢体麻木,风湿痹痛。
(2)黄鼠狼,为鼬科动物黄鼬Mustela sibirica Pallas。【性味归经】甘、温、有小毒。入肺、肾二经【功效主治】杀虫疗疮、温肾缩尿。治疥疮、疮溃不愈合、尿频。
(3)灵芝,为多孔菌科真菌赤芝Ganoderma lucidum(Leyss.exFr.)Karst.或紫芝Ganoderma sinense Zhao,Xu et Zhang的干燥子实体。收载于中国药典2015年版:【性味与归经】甘,平。归心、肺、肝、肾经。【功能与主治】补气安神,止咳平喘。用于心神不宁,失眠心悸,肺虚咳喘,虚劳短气,不思饮食。
(4)石昌蒲,为天南星科植物石菖蒲Acorus tatarinowii Schott的干燥根茎。【性味与归经】辛、苦,温。归心、胃经。收载于中国药典2015年版:【功能与主治】开窍豁痰,醒神益智,化湿开胃。用于神昏癫痫,健忘失眠,耳鸣耳聋,脘痞不饥,噤口下痢。
(5)远志,为远志科植物远Polygala tenuifolia Willd.或卵叶远志Polygalasibirica L.的干燥根。收载于中国药典2015年版:【性味与归经】苦、辛,温。归心、肾、肺经。【功能与主治】安神益智,交通心肾,祛痰,消肿。用于心肾不交引起的失眠多梦、健忘惊悸、神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
发明内容
本发明的目的是提供一种治疗狂躁症的中药组合物及其制备方法。
本发明治疗狂躁症的中药组合物在中医传统理论的基础上,结合民间用药经验,运用现代科学理论配制而成。具有组方严谨,药少力专,对狂躁症有良好的疗效,能有效改善患者的临床症状,缩短病程,提高患者的生活质量。
本发明所采用的技术方案如下:
一种治疗狂躁症的中药组合物,由以下重量份的组分组成:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份。
以上所述治疗狂躁症的中药组合物,优选由以下重量份的组分组成:天麻20-40份、黄鼠狼40-60份、灵芝15-25份、石昌蒲15-25份、远志15-25份。
以上所述治疗狂躁症的中药组合物,最佳优选由以下重量份的组分组成:天麻30份、黄鼠狼50份、灵芝20份、石昌蒲20份、远志20份。
以上所述治疗狂躁症的中药组合物,可制备成口服固体制剂或口服液体制剂,如:酒剂、丸剂、胶囊剂、散剂。作为优选,所述口服固体为丸剂,所述口服液体制度为酒剂。
以上所述治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份;
(3)取以上各味药材,碎断,置罐中,加8-10倍量55°白酒,加盖密封,浸泡30-50天后,过滤除去药材,即得。
以上所述治疗狂躁症的中药组合物制备成丸剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份;
(3)取黄鼠狼,碎断,置罐中,加8-10倍量55°白酒,加盖密封,蒸至酒尽,取出,60℃干燥后,粉碎成细粉,过100目筛;
(4)取天麻、远志,60℃干燥后,粉碎成细粉,过100目筛,备用;
(5)取灵芝、石昌蒲,加6-8倍量水煎煮提取2-3次,每次1-3小时,合并提取液,滤过,滤液减压浓缩至相对密度为在60℃时为1.25-1.28的稠膏;
(6)合并步骤(2)、(3)的细粉,混匀;
(7)将上述细粉和步骤(4)的稠膏混合,加适量黏合剂制成浓缩水丸、浓缩蜜丸或浓缩水蜜丸。
以上所述治疗狂躁症的中药组合物,在制备治疗狂躁症的药物中的用途。
本发明治疗狂躁症的中药组合物是在中医药传统理论的基础上,结合民间用药经验,运用现代科学理论配制而成。方中天麻,平抑肝阳,为君药。黄鼠狼温肾润肺,为臣药。灵芝,补气安神;石昌蒲,开窍豁痰,醒神益智,化湿开胃;二者合用为佐药。远志,安神益智,交通心肾,祛痰,为使药。诸药合用共奏涤痰开窍、安神益智之功。本发明组方严谨,药少力专,对狂躁症有良好的疗效。
本发明的有益效果是:
(1)组方严谨,药少力专,具有涤痰开窍、安神益智功能的功效,对狂躁症有良好的疗效,治疗总有效率达80%以上。
(2)组份均为中草药品种,使用安全,标本兼治,克服了西药治疗时治标不治本,病情反复发作和容易产生药物依赖,毒副作用大等缺点。
具体实施方式
下面结合具体实施例对本发明作进一步描述,但不限制本发明的保护范围和应用范围:
一、治疗狂躁症的中药组合物酒剂的制备
实施例1
一种治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻1kg、黄鼠狼3kg、灵芝1kg、石昌蒲1kg、远志1kg;
(3)取以上各味药材,碎断,置罐中,加8倍量55°白酒,加盖密封,浸泡50天后,过滤除去药材,即得。
实施例2
一种治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻2kg、黄鼠狼4kg、灵芝1.5kg、石昌蒲1.5kg、远志1.5kg;
(3)取以上各味药材,碎断,置罐中,加9倍量55°白酒,加盖密封,浸泡30天后,过滤除去药材,即得。
实施例3
一种治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻3kg、黄鼠狼5kg、灵芝2kg、石昌蒲2kg、远志2kg;
(3)取以上各味药材,碎断,置罐中,加9倍量55°白酒,加盖密封,浸泡40天后,过滤除去药材,即得。
实施例4
一种治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻4kg、黄鼠狼6kg、灵芝2.5kg、石昌蒲2.5kg、远志2.5kg;
(3)取以上各味药材,碎断,置罐中,加10倍量55°白酒,加盖密封,浸泡40天后,过滤除去药材,即得。
实施例5
一种治疗狂躁症的中药组合物制备成酒剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻5kg、黄鼠狼7kg、灵芝3kg、石昌蒲3kg、远志3kg;
(3)取以上各味药材,碎断,置罐中,加10倍量55°白酒,加盖密封,浸泡50天后,过滤除去药材,即得。
二、治疗狂躁症的中药组合物丸剂的制备
实施例6
一种治疗狂躁症的中药组合物制备成丸剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻3kg、黄鼠狼5kg、灵芝2kg、石昌蒲2kg、远志2kg;
(3)取黄鼠狼,碎断,置罐中,加9倍量55°白酒,加盖密封,蒸至酒尽,取出,60℃干燥后,粉碎成细粉,过100目筛;
(4)取天麻、远志,60℃干燥后,粉碎成细粉,过100目筛,备用;
(5)取灵芝、石昌蒲,加7倍量水煎煮提取2次,每次2小时,合并提取液,滤过,滤液减压浓缩至相对密度为在60℃时为1.27的稠膏;
(6)合并步骤(2)、(3)的细粉,混匀;
(7)将上述细粉和步骤(4)的稠膏混合,加适量水和炼蜜制成浓缩水蜜丸。
实施例7
一种治疗狂躁症的中药组合物制备成丸剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻1kg、黄鼠狼3kg、灵芝1kg、石昌蒲1kg、远志1kg;
(3)取黄鼠狼,碎断,置罐中,加8倍量55°白酒,加盖密封,蒸至酒尽,取出,60℃干燥后,粉碎成细粉,过100目筛;
(4)取天麻、远志,60℃干燥后,粉碎成细粉,过100目筛,备用;
(5)取灵芝、石昌蒲,加6倍量水煎煮提取3次,每次1小时,合并提取液,滤过,滤液减压浓缩至相对密度为在60℃时为1.25的稠膏;
(6)合并步骤(2)、(3)的细粉,混匀;
(7)将上述细粉和步骤(4)的稠膏混合,加适量炼蜜制成浓缩蜜丸。
实施例8
一种治疗狂躁症的中药组合物制备成丸剂的方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻5kg、黄鼠狼7kg、灵芝3kg、石昌蒲3kg、远志3kg;
(3)取黄鼠狼,碎断,置罐中,加10倍量55°白酒,加盖密封,蒸至酒尽,取出,60℃干燥后,粉碎成细粉,过100目筛;
(4)取天麻、远志,60℃干燥后,粉碎成细粉,过100目筛,备用;
(5)取灵芝、石昌蒲,加7倍量水煎煮提取2次,每次3小时,合并提取液,滤过,滤液减压浓缩至相对密度为在60℃时为1.28的稠膏;
(6)合并步骤(2)、(3)的细粉,混匀;
(7)将上述细粉和步骤(4)的稠膏混合,加适量水制成浓缩水丸。
三、临床应用试验
1、诊断标准
符合《中国精神障碍分类方案与诊断标准》第三版(CCMD-3)关于狂躁症的诊断标准,症状标准以情绪高涨或易激惹为主,该症状持续2周以上,并至少有下列3项(若仅为易激惹,至少需四项):(1)注意力不集中或随境转移;(2)语量增多;(3)思维奔逸(语速增快、言语迫促等)、联想加快或意念飘忽的体验;(4)自我评价过高或夸大;(5)精力充沛、不感疲乏、活动增多、难以安静,或不断改变计划和活动;(6)鲁莽行为(如挥霍、不负责任、或不计后果的行为等;(7)睡眠需要减少;(8)性欲亢进。
2、疗效判定
痊愈:症状完全消失,情绪稳定,自我评价正常;
显效:症状基本消失,情绪基本稳定,自我评价基本正常;
有效:症状有所减轻,部分症状基本消失,情绪基本稳定,自我评价基本正常;
无效:症状、情绪毫无改善,自我评价仍过高。
3、给药方法
A治疗组:给予口服实施例1-14的产品,1日3次,酒剂100ml/次,丸剂6g/次,连续1周为一疗程。
B对照组:给予口服碳酸锂,首次剂量200mg/次,2~4次/日,两周内加至600~2000mg/日。
4、应用结果
本发明治疗狂躁症的中药组合物,曾用于治疗和观察117例精神疾病患者。将上述制备好的8种实施例样品以及对照样品,分别用于狂躁症患者(男60例,女57例,平均年龄29岁)。结果详见下表。
应用结果表
实施例 | 痊愈(%) | 显效(%) | 有效(%) | 无效(%) | 总有效率(%) |
实施例1 | 30.8 | 23.1 | 30.8 | 15.4 | 84.6 |
实施例2 | 30.8 | 38.4 | 15.4 | 15.4 | 84.6 |
实施例3 | 38.5 | 38.5 | 15.3 | 7.7 | 92.3 |
实施例4 | 46.1 | 15.4 | 30.8 | 7.7 | 92.3 |
实施例5 | 46.1 | 30.8 | 15.4 | 7.7 | 92.3 |
实施例6 | 38.4 | 30.8 | 23.1 | 7.7 | 92.3 |
实施例7 | 30.8 | 15.4 | 38.4 | 15.4 | 84.6 |
实施例8 | 46.1 | 23.1 | 23.1 | 7.7 | 92.3 |
对照 | 30.8 | 38.4 | 7.7 | 23.1 | 76.9 |
结果表明:采用本发明治疗狂躁症的中药组合物,对狂躁病治疗的总有效率均达80%以,均高于对照组。说明本发明中药组合物对治疗狂躁症有良好的疗效,可以有效改狂躁症患者的症状,提高其生活质量,而且不会产生依赖性,副作用小。以下为几个典型例。
典型例1:李××,男,25岁,患狂躁症半年,表现为情绪高涨,语言明显增多,自我评价过高,注意力随意转移,精力充沛,难以安静,睡眠减少,反复发作。服用本发明实施例1,每次100ml,每日3次,连服7日后症状大大改善,情绪趋于稳定,再连服7日,症状全部消失,情绪恢复正常,痊愈,继续连服42日,一年半后不复发。
典型例2:何××,女,28岁,患病5个月,表现为情绪高涨,语言明显增多,语速明显加快,自我评价过高,注意力不集中,睡眠减少,但精力充沛,不感疲乏,伴有偏头痛,反复发作。服用本发明实施例6,每次6g,每日3次,连服14日后,症状基本消失、头痛减轻,情绪稳定,再连服42日,一年后不复发。
典型例3:黄××,女,32岁,近三个月来情绪高涨,精力过于旺盛,语言明显增多,语速明显加快,自我评价过高,认为自己能力超人,但是做事有头无尾,注意力不集中,睡眠减少,伴有偏头痛,反复发作。服用本发明实施例2,每次100ml,每日3次,连服15日后症状消失,恢复正常,痊愈。再连服42日,一年半后不复发。
典型例4:韦××,男,22岁,半年多来情绪高涨,行为鲁莽,言语迫促,注意力不集中,自我评价夸大,反得发作。服用本发明实施例4,每次100ml,每日3次,连服7日后症状基本消失,情绪稳定,再连服7日,症状全部消失,痊愈,再连服49日,一年后不复发。
典型例5:曾××,女,26岁,表现为语言明显增多,不停的高谈阔论,精力充沛,睡眠减少,自我评价夸大,爱管闲事,反复发作,伴有偏头痛,已持续半年多。服用本发明实施例8,每次6g,每日3次,连服7日后,症状基本消失、头痛减轻,情绪稳定,再连服7日,症状消失,痊愈,继续连服42日,两年后不复发。
Claims (10)
1.一种治疗狂躁症的中药组合物,其特征在于,由以下重量份的组分组成:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份。
2.根据权利要求1所述的治疗狂躁症的中药组合物,其特征在于,由以下重量份的组分组成:天麻20-40份、黄鼠狼40-60份、灵芝15-25份、石昌蒲15-25份、远志15-25份。
3.根据权利要求1所述的治疗狂躁症的中药组合物,其特征在于,由以下重量份的组分组成:天麻30份、黄鼠狼50份、灵芝20份、石昌蒲20份、远志20份。
4.根据权利要求1至3中任一所述的治疗狂躁症的中药组合物,其特征在于,所述中药组合物制成口服固体制剂或口服液体制剂。
5.根据权利要求4所述的治疗狂躁症的中药组合物,其特征在于,所述口服固体制剂为丸剂、胶囊剂或散剂。
6.根据权利要求4所述的治疗狂躁症的中药组合物,其特征在于,所述口服液体制剂酒剂。
7.根据权利要求5所述的治疗狂躁症的中药组合物,其特征在于,所述口服固体制剂为丸剂。
8.一种如权利要求6所述治疗狂躁症的中药组合物制备成酒剂的制备方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份;
(3)取以上各味药材,碎断,置罐中,加8-10倍量55°白酒,加盖密封,浸泡30-50天后,过滤除去药材,即得。
9.一种如权利要求7所述治疗狂躁症的中药组合物制备成丸剂的制备方法,包括以下步骤:
(1)分别取天麻、黄鼠狼、灵芝、石昌蒲、远志,黄鼠狼去皮毛、内脏,其余4味药材净选,干燥;
(2)按照以下重量份称取:天麻10-50份、黄鼠狼30-70份、灵芝10-30份、石昌蒲10-30份、远志10-30份;
(3)取黄鼠狼,碎断,置罐中,加8-10倍量55°白酒,加盖密封,蒸至酒尽,取出,60℃干燥后,粉碎成细粉,过100目筛;
(4)取天麻、远志,60℃干燥后,粉碎成细粉,过100目筛,备用;
(5)取灵芝、石昌蒲,加6-8倍量水煎煮提取2-3次,每次1-3小时,合并提取液,滤过,滤液减压浓缩至相对密度为在60℃时为1.25-1.28的稠膏;
(6)合并步骤(2)、(3)的细粉,混匀;
(7)将上述细粉和步骤(4)的稠膏混合,加适量黏合剂制成浓缩水丸、浓缩蜜丸或浓缩水蜜丸。
10.根据权利要求1-9中任一所述的治疗狂躁症的中药组合物,其特征在于,所述中药组合物在制备治疗精神疾病的药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611246700.4A CN106491996A (zh) | 2016-12-29 | 2016-12-29 | 一种治疗狂躁症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611246700.4A CN106491996A (zh) | 2016-12-29 | 2016-12-29 | 一种治疗狂躁症的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106491996A true CN106491996A (zh) | 2017-03-15 |
Family
ID=58334658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611246700.4A Pending CN106491996A (zh) | 2016-12-29 | 2016-12-29 | 一种治疗狂躁症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106491996A (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2425900A1 (en) * | 2000-10-18 | 2002-04-25 | Tzu-Sheng Wu | Novel medicinal herbal composition for treating liver diseases and hiv |
EE200400097A (et) * | 2001-12-14 | 2004-10-15 | Council Of Scientific And Industrial Research | Kompositsioon neurotserebrovaskulaarsete häirete ravimiseks ning meetod selles sisalduva kurkumiõlivalmistamiseks |
CN101507736A (zh) * | 2009-03-17 | 2009-08-19 | 候振发 | 治疗老年痴呆、坐骨腰椎、肿疖、受风多种痹症的中药制剂 |
CN102908587A (zh) * | 2012-10-29 | 2013-02-06 | 钟思冰 | 健脑益智丸治疗脑衰竭性精神病 |
CN104435775A (zh) * | 2014-11-18 | 2015-03-25 | 陈征 | 一种中药保健酒及其制备方法 |
CN105902963A (zh) * | 2016-05-30 | 2016-08-31 | 苏州市天灵中药饮片有限公司 | 一种安神解郁中药及其制备方法 |
-
2016
- 2016-12-29 CN CN201611246700.4A patent/CN106491996A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2425900A1 (en) * | 2000-10-18 | 2002-04-25 | Tzu-Sheng Wu | Novel medicinal herbal composition for treating liver diseases and hiv |
EE200400097A (et) * | 2001-12-14 | 2004-10-15 | Council Of Scientific And Industrial Research | Kompositsioon neurotserebrovaskulaarsete häirete ravimiseks ning meetod selles sisalduva kurkumiõlivalmistamiseks |
CN101507736A (zh) * | 2009-03-17 | 2009-08-19 | 候振发 | 治疗老年痴呆、坐骨腰椎、肿疖、受风多种痹症的中药制剂 |
CN102908587A (zh) * | 2012-10-29 | 2013-02-06 | 钟思冰 | 健脑益智丸治疗脑衰竭性精神病 |
CN104435775A (zh) * | 2014-11-18 | 2015-03-25 | 陈征 | 一种中药保健酒及其制备方法 |
CN105902963A (zh) * | 2016-05-30 | 2016-08-31 | 苏州市天灵中药饮片有限公司 | 一种安神解郁中药及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101032560B (zh) | 一种治疗睡眠障碍的中药组合物及制备方法 | |
CN104367665A (zh) | 一种治疗肩周炎的中药组合物及其制备方法 | |
CN105497261A (zh) | 一种外用贴剂基质及该基质制成的外用贴剂和助眠贴 | |
CN103007145B (zh) | 一种治疗小儿轮状病毒肠炎的中药组合物及其制备方法 | |
CN104740557A (zh) | 一种治疗风湿病的中药组合物、乳膏剂及其制备方法 | |
CN103798472B (zh) | 一种保健茶及保健养生制剂 | |
CN107982510A (zh) | 一种帮助戒烟的款冬花口服液及其制备方法 | |
CN106491996A (zh) | 一种治疗狂躁症的中药组合物及其制备方法 | |
CN106138785A (zh) | 一种治疗神经衰弱的中药组合物及其制备方法 | |
CN104225201A (zh) | 一种治疗咳嗽的药物组合物 | |
CN104225061A (zh) | 一种治疗气阴两虚型病毒性心肌炎的中药 | |
CN103127255A (zh) | 用于治疗哮喘的抗氧化中药外用敷贴配方及其制备方法 | |
CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
CN103705623B (zh) | 半仿生提取法在消除中药液体制剂中沉淀物的应用 | |
CN107737259A (zh) | 一种提高男性性功能的中药组方 | |
CN110179889B (zh) | 一种用于戒断海洛因毒瘾的中药组合物及其制备方法 | |
CN100443093C (zh) | 治疗艾滋病的药物 | |
CN107041923A (zh) | 一种具有清肺、止咳、化痰功能的组合物及其制备方法 | |
CN104524266A (zh) | 一种治疗儿童甲亢的离子导入剂的制备方法 | |
CN104547695B (zh) | 一种用于治疗三叉神经痛的药物组合物及其应用 | |
CN103655993B (zh) | 一种治疗中风的中药及其制备方法 | |
CN105194545B (zh) | 一种治疗哮喘的中药组合物 | |
CN105232995A (zh) | 一种治疗面瘫的中药 | |
CN104826072A (zh) | 一种治疗呼吸系统感染的中药制剂及其制备方法 | |
CN105521478A (zh) | 一种治疗惊悸失眠的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170315 |